JP Morgan keeps Clorox at Underweight and lifts target to $86
JP Morgan kept its Underweight rating on Clorox and raised its price target to $86 from $83, according to TradingView, citing Benzinga data.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
JP Morgan kept its Underweight rating on Clorox shares and raised its price target by 3.6%, to $86 from $83. TradingView reports that the new target implies a downside of 4.3% from the November 2 close of $89.90.
The same TradingView feed lists other recent notes from the past 30 days: UBS kept Neutral at $96, Wells Fargo kept Equal-Weight at $90, Evercore ISI upgraded to In-Line at $99, and Barclays kept Underweight at $80. Across the five most recent notes, targets range from $80 to $99. Data is provided by Benzinga.
why it matters
Analyst notes like this reflect current views rather than new company data, so their effect on the stock is usually limited. The spread of targets across recent notes shows that professional estimates for Clorox diverge. This is not investment advice.
tags
instruments
sources
- JP Morgan maintains Clorox at Underweight, raises price target to $86 from $83 — TradingView, 3 November 2026 at 17:43 UTC
- JP Morgan maintains Fox at Overweight, raises price target to $83 from $82 — TradingView, 3 November 2026 at 17:47 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗